Skip to content
10-Q

Quarterly Report

PROTO SCRIPT PHARMACEUTICAL CORP

0001640334-18-000434

← back to feed
Filed
Mar 8, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Mar 5, 2018 49.14M sh
Capex Q3 2017 · Sep 30, 2017 $21.62K
Capex Q3 2017 · Sep 30, 2016 $3K
Cash And Equivalents Q3 2017 · Sep 30, 2017 $0
Cash And Equivalents Q3 2017 · Dec 31, 2016 $3.51K
Cash And Equivalents Q3 2017 · Sep 30, 2016 $5.8K
Cash And Equivalents Q3 2017 · Dec 31, 2015 $9.09K
Stockholders Equity Q3 2017 · Sep 30, 2017 −$1.44M
Stockholders Equity Q3 2017 · Dec 31, 2016 −$319.74K
Current Liabilities Q3 2017 · Sep 30, 2017 $1.68M
Current Liabilities Q3 2017 · Dec 31, 2016 $489.93K
Current Assets Q3 2017 · Sep 30, 2017 $186.75K
Current Assets Q3 2017 · Dec 31, 2016 $144.65K
Total Assets Q3 2017 · Sep 30, 2017 $234.56K
Total Assets Q3 2017 · Dec 31, 2016 $170.19K
Sga Expense Q3 2017 · Sep 30, 2017 $299.23K
Sga Expense Q3 2017 · Sep 30, 2017 $942.57K
Sga Expense Q3 2017 · Sep 30, 2016 $174.28K
Sga Expense Q3 2017 · Sep 30, 2016 $482.37K
Net Income Q3 2017 · Sep 30, 2017 −$283.65K
Net Income Q3 2017 · Sep 30, 2017 −$1.12M
Net Income Q3 2017 · Dec 31, 2016 $7.18M
Net Income Q3 2017 · Sep 30, 2016 $149
Net Income Q3 2017 · Sep 30, 2016 $81.49K
Operating Income Q3 2017 · Sep 30, 2017 −$85.46K
Operating Income Q3 2017 · Sep 30, 2017 −$591.38K
Operating Income Q3 2017 · Sep 30, 2016 $149
Operating Income Q3 2017 · Sep 30, 2016 $81.49K
Gross Profit Q3 2017 · Sep 30, 2017 $213.78K
Gross Profit Q3 2017 · Sep 30, 2017 $351.19K
Gross Profit Q3 2017 · Sep 30, 2016 $174.43K
Gross Profit Q3 2017 · Sep 30, 2016 $563.85K
Cost Of Revenue Q3 2017 · Sep 30, 2017 $38.2K
Cost Of Revenue Q3 2017 · Sep 30, 2017 $153.44K
Cost Of Revenue Q3 2017 · Sep 30, 2016 $39.4K
Cost Of Revenue Q3 2017 · Sep 30, 2016 $124.76K
Dividends Paid Q3 2017 · Sep 30, 2016 $59.59K